ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA AdCom roster shrinks as two quit over Aduhelm approval firstwordpharma
June 10, 2021Mayo Clinic neurologist David Knopman on Wednesday became the second member of the FDA's Peripheral and Central Nervous System Drugs Advisory Committee (AdCom) to resign in protest at the agency's decision earlier this week to approve Biogen
Pharma Sources Insight January 2025
